相关实验视频
Updated: May 7, 2025

08:46
A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
Published on: August 12, 2020
6.2K
维生素D缺乏与晚期发病的新生儿败血症的关联 在期限和晚期早产新生儿中
M A Rabbany1, M N Islam, M Akhter
1Dr Md Arif Rabbany, Junior Consultant, Department of Neonatology, Mymensingh Medical College Hospital (MMCH), Mymensingh, Bangladesh;
Mymensingh medical journal : MMJ
|December 31, 2024
概括
新生儿败血症是婴儿死亡的主要原因,与新生儿及其母亲的维生素D缺乏密切相关. 母亲和婴儿的维生素D水平较低表明晚发新生儿败血症的风险较高.
科学领域:
- 新生儿科学 新生儿科学
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
背景情况:
- 新生儿败血症是一个关键的全球卫生问题,特别是在低收入和中等收入国家,为婴儿死亡率做出了重大贡献.
- 维生素D缺乏症越来越多地与新生儿不良后果有关,包括败血症,这是由于维生素D在免疫功能和平衡中的作用.
- 现有的数据突出显示了孟加拉国新生儿败血症的流行情况,强调需要确定导致因素.
研究的目的:
- 为了研究血清25(OH) 维生素D水平和晚期发作的新生儿败血症之间的关联,在到期和晚期早产婴儿.
- 为了比较新生儿有败血症的维生素D状况与没有败血症的对照组.
- 评估与新生儿败血症相关的母亲维生素D水平.
主要方法:
- 在孟加拉国进行的一项横截面分析研究.
- 包括怀疑晚发性败血症入院的新生儿和患有生理性高 bilirubinemia 的对照组.
- 测量了新生儿和母亲的血清25 (OH) 维生素D水平.
主要成果:
- 与对照组 (20.56±5.93 ng/ml) 相比,败血症的新生儿的血清维生素D水平明显较低 (13.99±6.07 ng/ml).
- 败血症新生儿的母亲也显示出比非败血症新生儿的母亲 (23.06±5.85 ng/ml) 的平均血清维生素D水平明显低 (16.36±6.25 ng/ml).
- 在新生儿和母亲的25-OH) 维生素D水平之间,在败血症和对照组中都观察到强烈的正相关性.
结论:
- 血清25(OH) 维生素D缺乏与晚期和晚期早产新生儿的晚期新生儿败血症显著相关.
- 母亲的维生素D状况与新生儿的维生素D状况有很强的相关性,可能在新生儿败血症风险中起作用.
- 解决母亲和新生儿的维生素D缺乏症可能是减少新生儿败血症负担的潜在策略.
相关概念视频
Development of Immunocompetence
233
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
233
Teratogenicity
2.3K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K
Immunodeficiency Diseases
823
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
823

